A spectrum of obesity requires precision 

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals - a company working to advance a greater understanding of how to effectively treat obesity - about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.